Daily Medication Pearl: Canagliflozin (Invokana)


Canagliflozin (Invokana) is indicated to improve glycemic control in adults with type 2 diabetes mellitus.

Medication Pearl of the Day: Canagliflozin (Invokana)

Indication: Canagliflozin (Invokana) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.


  • Dosing: The recommended starting dose is 100 mg once daily, taken before the first meal of the day.
  • Dosage forms: Tablets 100 mg, 300 mg.
  • Adverse events: Most common adverse reactions associated with canagliflozin (5% or greater incidence): female genital mycotic infections, urinary tract infection, and increased urination.
  • Mechanism of action: SGLT2 expressed in the proximal renal tubules is responsible for most of the reabsorption of filtered glucose from the tubular lumen. By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, thereby increasing urinary glucose excretion.
  • Manufacturer: Janssen Pharmaceuticals


Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Patient with diabetes testing blood sugar levels
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.